Voya Investment Management LLC Gossamer Bio, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $7,822 - $10,876	773 Added 3.31%	24,100 $273,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $978,240 - $1.19 Million	-122,280 Reduced 83.98%	23,327 $189,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $150,999 - $191,417	-17,497 Reduced 10.73%	145,607 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $1.21 Million - $1.98 Million	145,709 Added 837.65%	163,104 $1.58 Million
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $43,487 - $72,996	-4,568 Reduced 20.8%	17,395 $226,000
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $8,992 - $17,399	1,124 Added 5.39%	21,963 $223,000
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $75,389 - $136,280	5,087 Added 32.29%	20,839 $326,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $252,347 - $353,947	15,752 New	15,752 $264,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $90.2M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.